Early rheumatoid arthritis: therapeutic strategies.
暂无分享,去创建一个
[1] R. Eastell,et al. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.
[2] Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. , 1993, British journal of rheumatology.
[3] R. Holder,et al. Generalised bone loss in patients with early rheumatoid arthritis , 1994, The Lancet.
[4] J. Bell,et al. Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive associations with HLA-DR4, DR1 and DRw10. , 1991, British journal of rheumatology.
[5] P. Bacon,et al. Progression of radiological changes in rheumatoid arthritis. , 1984, Annals of the rheumatic diseases.
[6] V. Wright,et al. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. , 1984, Scandinavian journal of rheumatology.
[7] Paul Wordsworth,et al. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. , 1992, BMJ.
[8] S. Holbeck,et al. HLA-DR4-Associated Disease: Oligonucleotide Probes Identify Specific Class II Susceptibility Genes in Type I Diabetes and Rheumatoid Arthritis , 1989 .
[9] J. Bell,et al. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[10] B. McConkey,et al. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. , 1977, British medical journal.
[11] P. Dawes,et al. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. , 1986, British journal of rheumatology.
[12] T. Pincus,et al. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. , 1988, Journal of clinical epidemiology.
[13] P. Stastny. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.
[14] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[15] G. Rinaldi,et al. High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis. , 1992, Arthritis and rheumatism.